Page last updated: 2024-08-21

isoxazoles and Hyperlipemia

isoxazoles has been researched along with Hyperlipemia in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	2 (28.57)	29.6817
2010's	3 (42.86)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Adeli, K; Anakk, S; Baker, C; Dean, AE; Farr, S; Hoffman, S; Masoudpoor, H; Stankovic, B; Taher, J	1
Dai, G; Zhang, Y	1
Fu, X; Guan, M; Liu, Q; Liu, R; Pan, H; Sun, C; Wong, CW; Yang, M	1
Baldelli, F; Cipriani, S; D'Amore, C; Distrutti, E; Fiorucci, S; Mencarelli, A; Palladino, G; Renga, B	1
Berger, JP; Doebber, TW; Forrest, MJ; Jones, AB; Liu, K; Macnaul, KL; Moller, DE; Xu, L; Zhou, G	1
Barrera, G; Edwards, PA; Gonzalez, FJ; Lee, FY; Lee, H; Vales, C; Willson, TM; Zhang, Y	1
Daniels, DL; Debnath, ML; ElSourady, H; Hall, IH; Izydore, RA; Simlot, R; Wong, OT; Woodard, T	1

Trials

1 trial(s) available for isoxazoles and Hyperlipemia

Article	Year
Efﬁcacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China. Human psychopharmacology, 2012, Volume: 27, Issue:6 Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; China; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperlipidemias; Isoxazoles; Male; Metabolic Diseases; Paliperidone Palmitate; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Quinolones; Schizophrenia; Thiazoles; Weight Gain; Young Adult	2012

Article

Year

Efﬁcacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.

Human psychopharmacology, 2012, Volume: 27, Issue:6

Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; China; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperlipidemias; Isoxazoles; Male; Metabolic Diseases; Paliperidone Palmitate; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Quinolones; Schizophrenia; Thiazoles; Weight Gain; Young Adult

2012

Other Studies

6 other study(ies) available for isoxazoles and Hyperlipemia

Article	Year
Bile acid treatment and FXR agonism lower postprandial lipemia in mice. American journal of physiology. Gastrointestinal and liver physiology, 2020, 04-01, Volume: 318, Issue:4 Topics: Animals; Bile Acids and Salts; Cholesterol 7-alpha-Hydroxylase; Deoxycholic Acid; Exenatide; Gastric Emptying; Gene Expression Regulation; Hyperlipidemias; Insulin; Intestinal Mucosa; Intestines; Isoxazoles; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Postprandial Period; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Taurocholic Acid	2020
Activation of farnesoid X receptor promotes triglycerides lowering by suppressing phospholipase A2 G12B expression. Molecular and cellular endocrinology, 2016, 11-15, Volume: 436 Topics: Animals; Chenodeoxycholic Acid; Diet, High-Fat; Gene Expression Regulation; Group X Phospholipases A2; Hep G2 Cells; Humans; Hyperlipidemias; Isoxazoles; Ligands; Lipid Metabolism; Lipoproteins, VLDL; Male; Mice, Inbred C57BL; Mice, Knockout; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Triglycerides	2016
FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2013, Volume: 23, Issue:2 Topics: Acyl-CoA Oxidase; Animals; Apoptosis; Bile Acids and Salts; Blood Glucose; Cardiovascular Diseases; Chenodeoxycholic Acid; Dyslipidemias; Fibrosis; Hyperinsulinism; Hyperlipidemias; Insulin Resistance; Isoxazoles; Lipid Metabolism; Liver; Myocardium; Obesity; PPAR alpha; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Risk Factors; RNA, Messenger; Triglycerides	2013
Discovery of a novel series of peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes and dyslipidemia. Journal of medicinal chemistry, 2005, Apr-07, Volume: 48, Issue:7 Topics: 3T3-L1 Cells; Animals; Blood Glucose; Carrier Proteins; Chlorocebus aethiops; Cholesterol; COS Cells; Diabetes Mellitus, Type 2; Dogs; Fatty Acid-Binding Proteins; Humans; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Isoxazoles; Mice; Mice, Obese; PPAR alpha; PPAR gamma; Propionates; Radioligand Assay; RNA, Messenger; Structure-Activity Relationship; Transcriptional Activation; Triglycerides; Weight Gain	2005
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proceedings of the National Academy of Sciences of the United States of America, 2006, Jan-24, Volume: 103, Issue:4 Topics: 3-Hydroxybutyric Acid; Adenoviridae; Animals; Blood Glucose; Blotting, Northern; Blotting, Western; Cholesterol; Diabetes Mellitus, Experimental; DNA-Binding Proteins; Etoposide; Gluconeogenesis; Glucose; Glycogen; Hepatocytes; Hyperglycemia; Hyperlipidemias; Insulin; Insulin Resistance; Isoxazoles; Lipids; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Models, Statistical; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Time Factors; Transcription Factors; Triglycerides	2006
Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents. Pharmaceutical research, 1995, Volume: 12, Issue:1 Topics: Animals; Body Weight; Cholesterol; Hyperlipidemias; Hypolipidemic Agents; Isoxazoles; Lipoproteins; Male; Mice; Mice, Inbred Strains; Organ Size; Rats; Rats, Sprague-Dawley; Triglycerides	1995